[REVISION HISTORY]
Statins and glaucoma risk association study
Updated 1 time since CLSTR started tracking revisions of this situation.
What changed
2026-10-15 12:10 UTC → 2026-10-25 08:42 UTC ·
added
removed
A large-scale observational study published in the British Journal of Ophthalmology has linked the use of statins, which are commonly prescribed to lower cholesterol, to a reduced risk of developing open-angle glaucoma. Utilizing a the TriNetX global database to analyze records from approximately 420,000 165 million individuals, researchers compared over 210,000 statin users with a matched control group of 210,000 non-users. The study found that statin users had a 15% lower risk of being diagnosed with open-angle glaucoma over a five-year period compared to a control group. period. For patients already diagnosed with the condition, the research indicated that statin use was associated with a significantly lower need for various medical interventions. Specifically, users showed a 36% lower risk of incisional glaucoma surgery, a 55% lower risk of minimally invasive glaucoma surgery (MIGS), and a 60% lower risk of selective laser trabeculoplasty (SLT). Additionally, statin users were 11% to 12% less likely to require additional pressure-lowering eye drops. While Researchers from the findings suggest potential nerve-protecting effects, researchers University of California San Diego noted that while statins are primarily prescribed for cholesterol management, they may help prevent or delay the death of nerve cells. However, as these are medical record analyses analyses, they cannot prove causation causation, and that randomized controlled trials are necessary to confirm if statins directly protect the optic nerve.
Versions
- 2026-10-25 08:42 UTC Statins and glaucoma risk association study
- 2026-10-15 12:10 UTC Statins and glaucoma risk association study
Only revisions since CLSTR began indexing content versions appear here. Select a version to see what changed compared to the one before it.